With full membership, watch our educational and editorial videos, search the site, receive our newsletters, join discussions, download slides and much more.
Dr Valentin Fuster sits down with Drs Peter Berger, Anne Curtis, Tim Gardner, Tony Gershlick, Harlan Krumholz, Darren McGuire, Ileana Piņa, and Rita Redberg to discuss the lessons learned at the ACC 2010 Scientific Sessions, including why lower may not be better for blood pressure, why preventing diabetes does not necessarily reduce cardiovascular risk, and the future of the mitral-valve clip.
Do gender perceptions affect the way female physicians are treated in cardiology? Drs Melissa Walton-Shirley, Judith Hochman, Suzanne Oparil, and Lynne Warner Stevenson tackle this important question.
Studies suggest public smoking bans reduce the incidence of acute MI. So why is America not smoke-free? Dr Melissa Walton-Shirley discusses this important issue with the AHA's Nancy Brown and Dr Clyde Yancy.
Distinguished by a lifelong commitment to rigorous investigation, Dr Carl Pepine shares his life path and gives insight on tomorrow's cardiology leaders and why it may be increasingly difficult for medicine to keep attracting the best and brightest.
Join Drs Harrington and Blumenthal as they shine a light on real and perceived conflicts between researchers and industry in a discussion moderated by heartwire's Shelley Wood.
Watch Drs Bob Harrington, Sanjay Kaul, and Gregg Stone as they debate the future of ticagrelor in a discussion moderated by heartwire's Lisa Nainggolan.
Join Dr Robert Califf for a thoughtful and timely interview with Dr Ray Gibbons on the core values he learned in his career in science and medicine and why they are imperative for physicians to keep in mind when contemplating the future of healthcare reform.
Inspired from a series of case scenarios, Drs Garcia, Lima, and Bax contemplate difficult options based on the latest imaging findings and best practice.
AHA president Dr Clyde Yancy and CEO Nancy Brown share insights from the recent sessions and discuss ongoing initiatives with heartwire's Shelley Wood.
Join Drs Valentin Fuster, Roger Blumenthal, Bob Harrington, Judith Hochman, Sanjay Kaul, Suzanne Oparil, Gregg Stone, Lynne Warner Stevenson, and Bruce Wilkoff as they discuss important news from the Scientific Sessions and tackle the issue of too little, too soon in clinical trials today.
New agents and interventions are paving the way for revised modalities in the management of patients with atrial fibrillation. Join Drs Alpert and Delascio Lopes for a review of the latest findings and options.
Raised in a blue-collar neighborhood of Somerville, MA, Dr Bob Harrington was blessed to have a strong family and the Jesuits on his side as he traveled from "Yankee" Boston to Duke University. Join him as he tells his story to Dr Rob Califf.
How do regulatory pathways differ in the US and UK? Drs Harrington, Bhatt, and Cleland share their experiences and offer insight on how to support innovative research.
Dr Melissa Walton-Shirley talks to Dr Nassir Marrouche about the results of RE-LY, the impact of dronedarone on the treatment of atrial fibrillation, and his hopes for the future of MRI-guided ablation.
Join heartwire's Lisa Nainggolan as she talks to DrsFranz Messerli and Melissa Walton-Shirley about the results of the KYOTO HEART Study, what they mean for North American and European populations, and the future role of angiotensin-receptor blockers (ARBs).
With the ISIS-1 trial, Dr Peter Sleight and his team at Oxford changed the approach to cardiovascular research. Join Dr Robert Califf as he talks to Dr Sleight about his journey from London to San Francisco to Oxford and finally to Italy, where he discovered the music of the heart.
Drs Bonhoeffer and Kovac discuss size, sterility, location, presence of multidisciplinary teams, and imaging techniques - issues to consider in creating an ideal lab that can also adapt to future technologies and developments.
Join 'heartwire's Steve Stiles as he talks to Drs Nassir Marrouche and Clyde Yancy about MADIT-CRT, the potential benefits and costs for the heart-failure population in light of the trial, and about why the Europeans seem to be ahead of the guidelines in the European CRT Survey.
Is there an ideal blood-pressure goal? theheart.org's Dr Melissa Walton-Shirley catches up with hypertension expert and current president of the American Society of Hypertension, Dr Henry Black, to address this thorny issue and others.
Exactly three years after the DES firestorm ignited the World Congress of Cardiology in Barcelona, heartwire's Shelley Wood sifts through the ashes with Drs Tony Gershlick, Christian Spaulding, and Renu Virmani in a discussion on DES safety and what we've learned since September 2006.